secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0000950170-25-051663
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals dismisses Crowe LLP, appoints Deloitte as auditor
------------------------------------------------------------------------

- Audit Committee dismissed Crowe LLP as independent auditor effective April 1, 2025.
- No disagreements or reportable events in fiscal years 2023 and 2024 or interim period.
- Crowe's audit reports for 2023 and 2024 were unqualified and not modified.
- Deloitte & Touche LLP appointed as new auditor for fiscal year ending Dec 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017025051663/0000950170-25-051663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017025051663/eldn-20250401.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-051663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer